Metis Global Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-831	Closed	-$202K	–	775
2025 Q1	$202K	Buy	831 +119	+17%	+$35.8K	0.01%	731
2024 Q4	$234K	Buy	712 +30	+4%	+$10.2K	0.01%	716
2024 Q3	$228K	Sell	682 -346	-34%	-$110K	0.01%	712
2024 Q2	$281K	Sell	1,028 -20	-2%	-$5.82K	0.01%	661
2024 Q1	$362K	Buy	1,048 +14	+1%	+$4.6K	0.01%	626
2023 Q4	$334K	Sell	1,034 -48	-4%	-$15K	0.01%	633
2023 Q3	$388K	Buy	1,082 +103	+11%	+$39.7K	0.02%	583
2023 Q2	$371K	Buy	979 +86	+10%	+$35K	0.02%	583
2023 Q1	$428K	Buy	893 +229	+34%	+$107K	0.03%	516
2022 Q4	$279K	Buy	664 +166	+33%	+$67K	0.02%	540
2022 Q3	$208K	Buy	498 +79	+19%	+$39.4K	0.03%	496
2022 Q2	$208K	Buy	+419	New	+$218K	0.03%	508